INTRODUCTION {#S1}
============

There seems to be an unprecedented increase in the use of herbal products / phytopharmaceuticals / dietary supplement (HP/PP/DS) in industrialized countries with a more general acceptance than has been hitherto witnessed. Reports of patients combining allopathic medicines with HP/PP/DS usually without the doctors or other health care givers' knowledge or awareness have also been on the increase.[@B1],[@B2] Though there is a record of increase in acceptance level of complementary and alternative medicine (CAM) by pharmacists[@B3],[@B4], physicians[@B5],[@B6],[@B7] and other health care givers[@B8], the incidence of combining CAM with allopathic medicines without the awareness of the health professionals[@B1],[@B2],[@B9] may endanger therapy as a result of unexpected interactions and adverse drug reaction which may be traced to the use of the combinations.

Previous studies in industrialized countries[@B1],[@B10],[@B11] and developing countries[@B5],[@B6],[@B12] show a relatively poor knowledge of HP/PP/DS vis a vis interaction potential and toxic effects among health care givers. However, pharmacists generally seem to be more knowledgeable than physicians, who are in turn better informed than nurses and trainees.[@B11] There also seems to be better correlation with health care givers who use HP/PP/DS having better knowledge than those who do not.[@B11]

Literatures abound on the knowledge base of physicians and sometimes pharmacists with respect to HP/PP/DS in Europe, USA and some other developing nations such as Turkey and Malaysia. In Nigeria, however, extensive literature search shows that very little has been done on assessing the knowledge base of pharmacists on HP/PP/DS[@B12] and that apparently nothing has been done on assessing physicians. This study has therefore been designed to evaluate two groups of professionals that patients usually come across in the hospital -- the pharmacist and the physician. The use, acceptability, attitudes to and beliefs in HP/PP/DS and their knowledge base on interactions of some of the common HP/PP/DS, usually stocked in the pharmacies of secondary and tertiary hospitals in Nigeria, were evaluated in this study.

METHODS {#S2}
=======

A pilot study was carried out to itemize the herbal medicines used or stocked in government-owned secondary and tertiary care hospitals in the Southwestern part of Nigeria. Herbal medicines in this study are defined as refined or raw extracts of plant origin, excluding minerals and vitamins, formulated into pharmaceutical formulations such as tablet, capsule, syrup and other oral dosage forms.

Multivitamin formulations containing ginseng, Gingko biloba or dietary supplements, such as those used for sickle cell disease, were also regarded as herbal medicine. The study was conducted in compliance with the ethical requirements of studies involving human beings. Informed consent of the individuals was obtained before the questionnaires were administered and anonymity of the respondents was upheld.

Two states in the southwestern part of Nigeria were chosen for the study. In the locality, there are two teaching hospitals and over 30 secondary or general hospitals. In the capital cities of both states, all the secondary hospitals were chosen for the study.

Inclusion criteria were physicians and pharmacists in government hospital practice. The number of pharmacists was obtained from the administration office of each hospital. The number of physicians was obtained from the Department of Medicine in the teaching hospitals. Secondary hospitals had to be included due to the low number of pharmacists in the tertiary hospitals. Private hospitals were excluded from the studies because most of them use pharmacy technicians or nurses for drug dispensing. In all, there were 101 hospital pharmacists and 350 physicians. One hundred and fifty physicians gave their consent to take part in the study.

Twenty two and 24 item questionnaires were used to evaluate the use, attitude, belief and knowledge base of physicians and pharmacists respectively on herbal medicines and phytopharmaceuticals (HP/PP/DS) in the chosen study centres. The questionnaires were pre-tested among five hospital pharmacists and four physicians before distribution to the respondents.

In the case of physicians, demographic information such as age, sex, cadre in practice, number of years of post graduation, and, in the case of pharmacists, demographic data, years of experience (which may be different from years post of graduation), and area of specialization (for the physicians) were obtained. Multichoice questions regarding use, safety, knowledge and training of the physicians and pharmacists in the area of phytopharmaceuticals were also included. Eight questions were used to assess the knowledge of the physicians and pharmacists in the areas of indication and interaction potentials of the common phytopharmaceuticals available in most of the hospitals. Each question contained one right answer and three wrong answers. Correct answers to the questions were obtained from peer-reviewed journal articles on the subject.[@B13],[@B14],[@B15],[@B16][@B17],[@B18] The right answer to the question carried a score of "1", while a wrong answer carried a score of "0".

The limitation experienced in this study was the inaccessibility of the physician consultants and chief pharmacists. The excuses usually given were lack of time, for both parties and lack of interest in HP/PP/DS by the consultant physicians.

Descriptive statistics were used to evaluate the responses obtained. Comparison of the scores by the pharmacists and physicians, and the influence of certain variables on knowledge base were evaluated using Fisher's Exact test. Significant difference was set at p ≤ 0.05.

RESULTS {#S3}
=======

The response rate was 92% for physicians and 74% for hospital pharmacists. The distribution according to sex showed that there were more males than females for physicians (73.9% male; 26.1% females), while for pharmacists, the distribution was almost equal (43.2% male; 56.7% female). There were 64.8% grade 1 pharmacists, 22.9% senior pharmacists, 10.8% principal pharmacists and 1.4% chief pharmacists. The pharmacists who graduated in 1990-1995 were 8.1%; 29.7% in 1996-2000 and 62.2% in 2001-2006. Majority (72.9%) had been practising for 1-5 years, 25.1%, 6-10 years and 1.35%, 11-15 years. There were 61.95% house officers, 30.4% registrars, 6.5% senior registrars and 1.1% consultants. Majority of the physicians (85.9%) had been practising for 1-5 years, 13.0% for 6-10 years, and 1.1% for 11-15 years.

Almost half of the pharmacists (46.5%) found the training they had adequate while a higher number (51.4%) believed that the training was not adequate, and that there is a need to have more intensive training in the field of herbal medicine than the one they had in the university. Only 1.1% were not sure whether or not pharmacists had adequate capability in the field of phytomedicine/phytotherapy. A large number of pharmacists (67.6%) claimed that patients request for phytopharmaceuticals while only 15.2% physicians claimed that they had requests for phytopharmaceuticals from patients. A low number of pharmacists (13.5%) had requests for phytopharmaceuticals on a weekly basis while 47.3% had them on a monthly basis. Most pharmacists (80%) believed phytopharmaceuticals are safe and could be effective if properly administered. The remaining 20% were not too sure of the efficacy and safety. A large number of physicians, 44.6%, believed they were not safe and 18.5% believed they were not effective. 3.3% and 7.6% believed they were safe and effective respectively while 1.1% believed they only had placebo-effect; 26.1% had no idea about the safety and efficacy of this group of pharmaceuticals.

When asked on the steps taken after reports of possible interactions or adverse drug reactions (ADR) were made, 31.1% of pharmacists (majority of whom graduated between 1996 and 2000) and 13% of physicians (majority of whom graduated between 2001 and 2006) claimed they reported to the institutional pharmacovigilance centers. Others simply informed the patients to stop using the offending agent. Some examples of the interaction or adverse reactions given by the patients included nausea (34.5%), itching of the skin (23.2%) and headache (50%) which stopped when the HP/PP/DS was withdrawn. A large number of pharmacists (67.6%) believed interactions are possible with phytopharmaceuticals while 17.6% believed interactions are not possible. The remaining 14.8% were not sure. On the other hand,

29.3% physicians believed it was possible for phytopharmaceuticals to interact with other drugs while 10.9% believed it was not possible. Others (59.8%) were not sure. In-between professions, cadre and year of graduation had a significant effect (p\<\<0.05) on the perception of the possibilities of phytopharmaceuticals interacting with other drugs. For pharmacists, more respondents with 5 years or less of post graduation experience (33.4%) believed in possibility of interactions than physicians with the same years of post graduation experience (26%). The same effect was also observed with respondents with 7 -- 11 years of graduation experience (23.8% pharmacists and 2.2% physicians). A lower number of pharmacists (14.9%) than physicians (59.8%) claimed not to be aware that HP/PP/DS could interact with allopathic agents while a higher number of pharmacists (67.6%) and 29.3% physicians believed that HP/PP/DS could interact. Examples of the interactions given by the pharmacists include anticoagulant effect of warfarin which is potentiated by co administration of extracts of Gingko biloba or garlic.

Physicians (34.8%) believed that only doctors should recommend HP/PP/DS to patients and 45.7% physicians believed it should be pharmacists. Almost twenty percent were of the opinion that the recommendation should be left to traditional medical practitioners (TMPs). Pharmacists (78.4%), on the other hand believed that the recommendation should be done by pharmacists due to their training in HP/PP/DS, while 18.8% believed it should be by both doctors and pharmacists; 2.4% believed it should be handled by TMPs. Neither believed that patent medicine dealers should be allowed to recommend HP/PP/DS. All the pharmacists believed that the National Agency for Food & Drug Administration and Control (NAFDAC) should be allowed to regulate the manufacture, sales and supply of HP/PP/DS as it is being presently done. One of the pharmacists also suggested that the Traditional Medical Board (TMB) should be involved. A large number of the physicians, 83.7%, believed that NAFDAC should be in control but 19.5% believed that it should be done by NAFDAC in conjunction with the Medical Council of Nigeria and 32.6%, NAFDAC and the Pharmacists Council of Nigeria. Others (3.3%) believed it should be handled by the TMB. [Table 1](#T1){ref-type="table"} shows the scores obtained by the physicians and pharmacists based on their cadre and years of practice.

###### 

Influence of certain variables on the scores obtained by pharmacists and physicians

  ------------------- ---------------------------------------- ------------- ------------ --- ----------------
  Variable            Number of respondents obtaining scores   P value                        
  \< 50%              ≥ 50%                                                                   
  Pharmacists         Physicians                               Pharmacists   Physicians       
  Cadre                                                                                       
  GP 1/Registrar      17                                       26            31           2   0.0001\*\*\*
  PP/SR               2                                        5             6            1   0.1026^NS^
  Years of Practice                                                                           
  1-5                 18                                       78            36           1   \<0.0001\*\*\*
  6-10                6                                        9             13           3   0.0290\*\*
  General             24                                       87            50           5   \<0.0001\*\*\*
  ------------------- ---------------------------------------- ------------- ------------ --- ----------------

GP1 -- Grade 1 Pharmacist; PP -- Principal Pharmacist; SR -- Senior Registrar; \*\*\* - extremely significant; \*\* - significant; NS -- not significant

DISCUSSION {#S4}
==========

In both groups of professionals, there was obvious reluctance on the part of the senior professionals to take part in the study. Reasons given when interviewed were lack of time (by the chief pharmacists) and lack of interest in HP/PP/DS (by the consultant physicians). This may have a negative impact on their junior colleagues.

On the issue of training, the pharmacists had more training at both formal and informal levels than the physicians. This is probably due to the pharmacy curriculum which includes topics in herbal medicines and related areas in the course of the Bachelor of Pharmacy degree training. The continuing education programme for recertification of pharmacists has also exposed some of the older pharmacists to some of the recent findings in HP/PP/DS. Scores obtained by pharmacists in the use and interaction of HP/PP/DS with allopathic agents confirmed that they had better training in HP/PP/DS. This training, which is part of the bachelor of pharmacy degree programme, was however rated as being inadequate by majority of the pharmacists. This seems the worldwide trend as pharmacists would want to know as much about HP/PP/DS as they do about allopathic agents. The physicians also underwent a mixture of formal and informal training but did not pass any comment on the adequacy of their training. The pharmacists believed they would gain a lot from a formal training, and advocated that the curriculum for the Bachelor of Pharmacy degree and continuing education have more elements of topics in pharmacology of herbal medicines, resembling their counterparts' in community practice in Nigeria[@B12], Singapore[@B3] and the United States.[@B19] Previous studies[@B10],[@B11] showed that in Western countries, physicians are not adequately knowledgeable about HP/PP/DS. The contrast is the case in Trinidad[@B6] and Malaysia[@B5] which are not western in orientation. Here, the physicians accept the use of HP/PP/DS and even recommend it to their patients. Since use has also been associated with better knowledge[@B11], the result from the present study may be due to non acceptance of HP/PP/DS by majority of the physicians. Their opinion about the safety of HP/PP/DS showed that only 9.9% believed they were safe and or effective. There is also a wide discrepancy in the number of patients who approach each group of professionals for HP/PP/DS. This may be due to the patients' perception that the physicians are not so receptive to the use of HP/PP/DS. The discrepancy between the number of pharmacists who claimed to have received prescriptions for phytopharmaceuticals and the physicians who wrote the prescriptions shows that there is a serious difference probably in what is regarded as a HP/PP/DS by both professionals, even with HP/PP/DS defined on the questionnaires. The low number of physicians who prescribe phytopharmaceuticals is also most probably due to the perception of physicians regarding the efficacy and safety of herbs. Pharmacists tend to have a more regular request for HP/PP/DS. This is confirmed by the number of seeming interactions or adverse drug reactions (ADR) due to the use of HP/PP/DS that were reported by the pharmacists. There were twice more pharmacists than physicians who had received reports of interaction and ADRs. The step taken by both professionals thereafter was inadequate. The patients were asked to stop taking the offending agents and the number of reports made to the several pharmacovigilance centers in their area is insignificant compared to the complaints obtained. Again, the low number of reports made could be due to the level of unbelief that this class of medicines may not interact. This response could be confirmed from their responses to the potentials of HP/PP/DS interacting with allopathic agents (67.6% pharmacists against 29.3% physicians). Virtually all the pharmacists believed that NAFDAC should be allowed to monitor and regulate sales and supply of HP/PP/DS, an opinion shared by the physicians even though they believed other agencies such as the Medical Council of Nigeria and the Pharmacists Council of Nigeria should be involved alongside NAFDAC. All the pharmacists also believed that due to their exposure to training in herbal medicines, they are best fit to recommend HP/PP/DS to patients, but a large number of physicians did not share this opinion.

Years of experience had a positive effect on the ability of the pharmacists to score above 50% in the test. For the physicians, however, years of graduation/years of experience had no effect on the score. Neither those with many years of experience nor those with less than 5 years experience had a good score, confirming a study in the US by Suchard et al[@B10] in which clinical experience, among other factors, did not correlate significantly with the physicians' knowledge of adverse effects of herbal medicines. Years of practice as hospital pharmacists generally favored pharmacists' knowledge base. New pharmacy graduates had higher scores than those who had graduated over 6 years before the study. Generally, the pharmacists had higher scores than the physicians.

CONCLUSIONS {#S5}
===========

There is a wide gap in the knowledge of physicians when compared to that of hospital pharmacists in the pharmacology of herbal medicines and phytopharmaceuticals. There is a need to include some of the important topics on the pharmacology of common herbs in the locality in the curriculum and in the existing continuing education programmes, workshops, seminars and knowledge update organized for these two health care professionals. This will help them to recognize some of the ADRs that may come up as a result of ingestion of HP/PP/DS, the inherent dangers involved in combining them with allopathic agents and counsel patients' knowledgeably on their use of phytopharmaceuticals. Also, pharmacovigilance centers where information can be disseminated to other health care professionals on some of the cases of herb-drug interactions and herb ADRs observed in hospitals are not adequately used. There is a need to intensify and educate health care professionals on the importance and usefulness of pharmacovigilance centers to patient care.
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